Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis
Ghrelin is an appetite‐regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS‐R). Recently, high ghrelin levels have been detected in various types of human cancer. Ghrelin expression is observed in proximal and distal renal tu...
Saved in:
Published in | The Journal of pathology Vol. 237; no. 1; pp. 50 - 61 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.09.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Ghrelin is an appetite‐regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS‐R). Recently, high ghrelin levels have been detected in various types of human cancer. Ghrelin expression is observed in proximal and distal renal tubules, where renal cell carcinoma (RCC) arises. However, whether ghrelin is up‐regulated and promotes renal cell carcinogenesis remains obscure. In this study, we observed that ghrelin was highly expressed in renal tumours, especially in metastatic RCC. In addition, high ghrelin levels correlated with poor outcome, lymph node and distant metastasis. The addition of ghrelin promoted the migration ability of RCC cell lines 786–0, ACHN and A‐498. Furthermore, knockdown of ghrelin expression reduced in vitro migration and in vivo metastasis, suggesting a requirement for ghrelin accumulation in the microenvironment for RCC metastasis. Analysis of microarray signatures using Ingenuity Pathway Analysis (IPA) and MetaCore pointed to the potential regulation by ghrelin of Snail, a transcriptional repressor of E‐cadherin. We further observed that Ghrelin increased the expression, nuclear translocation and promoter‐binding activity of Snail. Snail silencing blocked the ghrelin‐mediated effects on E‐cadherin repression and cell migration. Snail–E‐cadherin regulation was mediated by GHS‐R‐triggered Akt phosphorylation at Ser473 and Thr308. Pretreatment with PI3K inhibitors, LY294002 and wortmannin, as well as Akt siRNA, decreased ghrelin‐induced Akt phosphorylation, Snail promoter binding activity and migration. Taken together, our findings indicate that ghrelin can activate Snail function via the GHS‐R–PI3K–Akt axis, which may contribute to RCC metastasis. The microarray raw data were retrieved from the Cancer Genome Atlas (TCGA) [KIRC gene expression (IlluminaHiSeq) dataset]. Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
---|---|
AbstractList | Ghrelin is an appetite‐regulating molecule that promotes growth hormone (
GH
) release and food intake through growth hormone secretagogue receptor (
GHS
‐R). Recently, high ghrelin levels have been detected in various types of human cancer. Ghrelin expression is observed in proximal and distal renal tubules, where renal cell carcinoma (
RCC
) arises. However, whether ghrelin is up‐regulated and promotes renal cell carcinogenesis remains obscure. In this study, we observed that ghrelin was highly expressed in renal tumours, especially in metastatic
RCC
. In addition, high ghrelin levels correlated with poor outcome, lymph node and distant metastasis. The addition of ghrelin promoted the migration ability of
RCC
cell lines 786–0,
ACHN
and A‐498. Furthermore, knockdown of ghrelin expression reduced
in vitro
migration and
in vivo
metastasis, suggesting a requirement for ghrelin accumulation in the microenvironment for
RCC
metastasis. Analysis of microarray signatures using Ingenuity Pathway Analysis (
IPA
) and
MetaCore
pointed to the potential regulation by ghrelin of Snail, a transcriptional repressor of
E‐cadherin
. We further observed that Ghrelin increased the expression, nuclear translocation and promoter‐binding activity of Snail. Snail silencing blocked the ghrelin‐mediated effects on E‐cadherin repression and cell migration. Snail–E‐cadherin regulation was mediated by
GHS
‐R‐triggered Akt phosphorylation at Ser473 and Thr308. Pretreatment with
PI3K
inhibitors,
LY294002
and wortmannin, as well as Akt
siRNA
, decreased ghrelin‐induced Akt phosphorylation, Snail promoter binding activity and migration. Taken together, our findings indicate that ghrelin can activate Snail function via the
GHS
‐R–
PI3K
–Akt axis, which may contribute to
RCC
metastasis. The microarray raw data were retrieved from the Cancer Genome Atlas (
TCGA
) [
KIRC
gene expression (
IlluminaHiSeq
) dataset]. Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Ghrelin is an appetite-regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS-R). Recently, high ghrelin levels have been detected in various types of human cancer. Ghrelin expression is observed in proximal and distal renal tubules, where renal cell carcinoma (RCC) arises. However, whether ghrelin is up-regulated and promotes renal cell carcinogenesis remains obscure. In this study, we observed that ghrelin was highly expressed in renal tumours, especially in metastatic RCC. In addition, high ghrelin levels correlated with poor outcome, lymph node and distant metastasis. The addition of ghrelin promoted the migration ability of RCC cell lines 786-0, ACHN and A-498. Furthermore, knockdown of ghrelin expression reduced in vitro migration and in vivo metastasis, suggesting a requirement for ghrelin accumulation in the microenvironment for RCC metastasis. Analysis of microarray signatures using Ingenuity Pathway Analysis (IPA) and MetaCore pointed to the potential regulation by ghrelin of Snail, a transcriptional repressor of E-cadherin. We further observed that Ghrelin increased the expression, nuclear translocation and promoter-binding activity of Snail. Snail silencing blocked the ghrelin-mediated effects on E-cadherin repression and cell migration. Snail-E-cadherin regulation was mediated by GHS-R-triggered Akt phosphorylation at Ser473 and Thr308. Pretreatment with PI3K inhibitors, LY294002 and wortmannin, as well as Akt siRNA, decreased ghrelin-induced Akt phosphorylation, Snail promoter binding activity and migration. Taken together, our findings indicate that ghrelin can activate Snail function via the GHS-R-PI3K-Akt axis, which may contribute to RCC metastasis. The microarray raw data were retrieved from the Cancer Genome Atlas (TCGA) [KIRC gene expression (IlluminaHiSeq) dataset]. Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Ghrelin is an appetite-regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS-R). Recently, high ghrelin levels have been detected in various types of human cancer. Ghrelin expression is observed in proximal and distal renal tubules, where renal cell carcinoma (RCC) arises. However, whether ghrelin is up-regulated and promotes renal cell carcinogenesis remains obscure. In this study, we observed that ghrelin was highly expressed in renal tumours, especially in metastatic RCC. In addition, high ghrelin levels correlated with poor outcome, lymph node and distant metastasis. The addition of ghrelin promoted the migration ability of RCC cell lines 786-0, ACHN and A-498. Furthermore, knockdown of ghrelin expression reduced in vitro migration and in vivo metastasis, suggesting a requirement for ghrelin accumulation in the microenvironment for RCC metastasis. Analysis of microarray signatures using Ingenuity Pathway Analysis (IPA) and MetaCore pointed to the potential regulation by ghrelin of Snail, a transcriptional repressor of E-cadherin. We further observed that Ghrelin increased the expression, nuclear translocation and promoter-binding activity of Snail. Snail silencing blocked the ghrelin-mediated effects on E-cadherin repression and cell migration. Snail-E-cadherin regulation was mediated by GHS-R-triggered Akt phosphorylation at Ser473 and Thr308. Pretreatment with PI3K inhibitors, LY294002 and wortmannin, as well as Akt siRNA, decreased ghrelin-induced Akt phosphorylation, Snail promoter binding activity and migration. Taken together, our findings indicate that ghrelin can activate Snail function via the GHS-R-PI3K-Akt axis, which may contribute to RCC metastasis. The microarray raw data were retrieved from the Cancer Genome Atlas (TCGA) [KIRC gene expression (IlluminaHiSeq) dataset].Ghrelin is an appetite-regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS-R). Recently, high ghrelin levels have been detected in various types of human cancer. Ghrelin expression is observed in proximal and distal renal tubules, where renal cell carcinoma (RCC) arises. However, whether ghrelin is up-regulated and promotes renal cell carcinogenesis remains obscure. In this study, we observed that ghrelin was highly expressed in renal tumours, especially in metastatic RCC. In addition, high ghrelin levels correlated with poor outcome, lymph node and distant metastasis. The addition of ghrelin promoted the migration ability of RCC cell lines 786-0, ACHN and A-498. Furthermore, knockdown of ghrelin expression reduced in vitro migration and in vivo metastasis, suggesting a requirement for ghrelin accumulation in the microenvironment for RCC metastasis. Analysis of microarray signatures using Ingenuity Pathway Analysis (IPA) and MetaCore pointed to the potential regulation by ghrelin of Snail, a transcriptional repressor of E-cadherin. We further observed that Ghrelin increased the expression, nuclear translocation and promoter-binding activity of Snail. Snail silencing blocked the ghrelin-mediated effects on E-cadherin repression and cell migration. Snail-E-cadherin regulation was mediated by GHS-R-triggered Akt phosphorylation at Ser473 and Thr308. Pretreatment with PI3K inhibitors, LY294002 and wortmannin, as well as Akt siRNA, decreased ghrelin-induced Akt phosphorylation, Snail promoter binding activity and migration. Taken together, our findings indicate that ghrelin can activate Snail function via the GHS-R-PI3K-Akt axis, which may contribute to RCC metastasis. The microarray raw data were retrieved from the Cancer Genome Atlas (TCGA) [KIRC gene expression (IlluminaHiSeq) dataset]. Ghrelin is an appetite-regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS-R). Recently, high ghrelin levels have been detected in various types of human cancer. Ghrelin expression is observed in proximal and distal renal tubules, where renal cell carcinoma (RCC) arises. However, whether ghrelin is up-regulated and promotes renal cell carcinogenesis remains obscure. In this study, we observed that ghrelin was highly expressed in renal tumours, especially in metastatic RCC. In addition, high ghrelin levels correlated with poor outcome, lymph node and distant metastasis. The addition of ghrelin promoted the migration ability of RCC cell lines 786-0, ACHN and A-498. Furthermore, knockdown of ghrelin expression reduced in vitro migration and in vivo metastasis, suggesting a requirement for ghrelin accumulation in the microenvironment for RCC metastasis. Analysis of microarray signatures using Ingenuity Pathway Analysis (IPA) and MetaCore pointed to the potential regulation by ghrelin of Snail, a transcriptional repressor of E-cadherin. We further observed that Ghrelin increased the expression, nuclear translocation and promoter-binding activity of Snail. Snail silencing blocked the ghrelin-mediated effects on E-cadherin repression and cell migration. Snail-E-cadherin regulation was mediated by GHS-R-triggered Akt phosphorylation at Ser473 and Thr308. Pretreatment with PI3K inhibitors, LY294002 and wortmannin, as well as Akt siRNA, decreased ghrelin-induced Akt phosphorylation, Snail promoter binding activity and migration. Taken together, our findings indicate that ghrelin can activate Snail function via the GHS-R-PI3K-Akt axis, which may contribute to RCC metastasis. The microarray raw data were retrieved from the Cancer Genome Atlas (TCGA) [KIRC gene expression (IlluminaHiSeq) dataset]. |
Author | Hsu, Shih-Lan Lin, Tsung-Chieh Hsiao, Michael Liu, Yu-Peng Chan, Yung-Chieh Su, Chia-Yi Yang, Chung-Shi Lin, Yuan-Feng |
Author_xml | – sequence: 1 givenname: Tsung-Chieh surname: Lin fullname: Lin, Tsung-Chieh organization: Genomics Research Centre, Academia Sinica, Taipei, Taiwan – sequence: 2 givenname: Yu-Peng surname: Liu fullname: Liu, Yu-Peng organization: Department of Genome Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan – sequence: 3 givenname: Yung-Chieh surname: Chan fullname: Chan, Yung-Chieh organization: Genomics Research Centre, Academia Sinica, Taipei, Taiwan – sequence: 4 givenname: Chia-Yi surname: Su fullname: Su, Chia-Yi organization: Genomics Research Centre, Academia Sinica, Taipei, Taiwan – sequence: 5 givenname: Yuan-Feng surname: Lin fullname: Lin, Yuan-Feng organization: Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan – sequence: 6 givenname: Shih-Lan surname: Hsu fullname: Hsu, Shih-Lan email: mhsiao@gate.sinica.edu.tw organization: Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan – sequence: 7 givenname: Chung-Shi surname: Yang fullname: Yang, Chung-Shi email: mhsiao@gate.sinica.edu.tw organization: Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli, Taiwan – sequence: 8 givenname: Michael surname: Hsiao fullname: Hsiao, Michael email: mhsiao@gate.sinica.edu.tw organization: Genomics Research Centre, Academia Sinica, Taipei, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25925728$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kV9LHDEUxUOx1FX70C9QAn3Rh9EkM0lmHkXqWpBWqLKlL-FOJtONziTbJOufb2-mu_ZBWggJl_s755Jz99CO884g9IGSY0oIO1lBWh5XnLM3aEZJI4qmbsQOmuUeK8qKyl20F-MtIaRpOH-HdhlvGJesnqG7-TKYwTq8Cn70yUQcjIMBazPkC4K2zo-AR5Mg5mMjvreAvzuwAwad7D0k6x0G1-Hcgxi9tpBMhx9sWuKV92Fy_uV8lh6gtz0M0bzfvvvo5vzz9dlFcflt_uXs9LLQlaCsaCVv-wqINlSKrmKkZIIa0XV9XVd9z3SjCREcetoYwqsul9DzjsmqJW1Tk3IfHW588-TfaxOTGm2cPgTO-HVUVBImOKV1ndFPr9Bbvw45gA1FapFHZerjllq3o-nUKtgRwpN6iTEDJxtABx9jML3SNv1JJoWclKJETYtS06LUtKisOHqleDH9F7t1f7CDefo_qK5Ory-2imKjsDGZx78KCHdKyFJytfg6V_RnfS6vFj_UonwGhkuylA |
CitedBy_id | crossref_primary_10_1007_s00018_015_2048_2 crossref_primary_10_3892_ol_2021_13054 crossref_primary_10_1016_j_bbcan_2017_02_002 crossref_primary_10_1186_s40880_016_0178_z crossref_primary_10_3390_biom12040517 crossref_primary_10_1158_1541_7786_MCR_16_0288 crossref_primary_10_1186_s12876_022_02510_8 crossref_primary_10_1038_s41388_018_0413_y crossref_primary_10_1155_2021_5576808 crossref_primary_10_1186_s13062_021_00293_8 crossref_primary_10_18632_oncotarget_7681 crossref_primary_10_1016_j_bbrc_2018_03_031 crossref_primary_10_1590_2359_3997000000290 crossref_primary_10_1186_s13018_024_05261_2 crossref_primary_10_1016_j_arr_2023_102115 crossref_primary_10_1186_s12885_016_2237_x crossref_primary_10_18632_oncotarget_14552 crossref_primary_10_1096_fj_202002159R crossref_primary_10_1177_03936155221110247 crossref_primary_10_3892_mmr_2021_12302 crossref_primary_10_1016_j_bbcan_2022_188715 crossref_primary_10_3892_ol_2019_10821 crossref_primary_10_3390_ijms221910571 crossref_primary_10_1016_j_ajpath_2024_07_003 crossref_primary_10_1038_ctg_2016_64 crossref_primary_10_3390_cancers14010111 crossref_primary_10_1097_MD_0000000000020635 crossref_primary_10_1111_cen_13725 crossref_primary_10_1016_j_jbc_2021_101111 crossref_primary_10_3389_fonc_2019_01014 crossref_primary_10_3389_fcell_2021_595914 crossref_primary_10_1007_s10528_020_10022_x crossref_primary_10_1038_srep20475 crossref_primary_10_3390_cancers11030303 crossref_primary_10_1111_neup_12315 crossref_primary_10_3892_etm_2019_8398 crossref_primary_10_1007_s13577_019_00245_5 crossref_primary_10_3390_biomedicines11123276 |
Cites_doi | 10.1016/j.peptides.2011.11.001 10.1074/jbc.M600223200 10.1055/s-0029-1233462 10.1016/j.regpep.2004.08.031 10.1242/dev.00238 10.1158/0008-5472.CAN-07-2318 10.1016/j.ccr.2007.11.004 10.1158/1078-0432.CCR-05-2250 10.1016/j.ceb.2003.11.001 10.1210/jc.2003-032118 10.1016/S0022-5347(05)65640-6 10.1007/s11373-007-9230-y 10.1002/jcb.23209 10.1038/nrm1490 10.1158/0008-5472.CAN-09-4481 10.1016/S0014-5793(00)02308-5 10.1158/0008-5472.CAN-07-2938 10.1038/nrc1276 10.1038/nrm757 10.1016/0006-291X(90)91263-R 10.1158/0008-5472.CAN-07-0575 10.1158/0008-5472.CAN-04-3480 10.1056/NEJM199609193351207 10.1016/S1471-4892(02)00220-5 10.1073/pnas.1209590109 10.1016/S0022-5347(01)67725-5 10.1007/s11864-003-0037-4 10.1016/j.cellsig.2004.10.011 10.1038/nrc822 10.1002/path.2365 10.1038/32433 10.1038/35000025 10.1038/ncb1173 10.1016/j.bbrc.2003.08.024 10.1038/35038090 10.1038/sj.bjc.6605530 10.1111/j.1464-410X.2007.07238.x 10.1016/S0140-6736(09)60229-4 10.1371/journal.pone.0016654 10.1373/clinchem.2004.032482 10.1007/s10585-008-9174-2 10.1530/EJE-09-0073 10.1006/bbrc.2001.4518 10.1038/35086018 10.1083/jcb.200207165 10.1016/S0167-0115(01)00243-9 10.1126/science.1196154 10.1038/emboj.2008.178 10.1038/35096067 10.1245/s10434-012-2347-x 10.1158/1541-7786.MCR-12-0160 10.1158/0008-5472.CAN-07-2559 10.1038/35000034 10.1016/S0378-1119(00)00371-1 |
ContentType | Journal Article |
Copyright | Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2015 Pathological Society of Great Britain and Ireland |
Copyright_xml | – notice: Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. – notice: Copyright © 2015 Pathological Society of Great Britain and Ireland |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1002/path.4552 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef Genetics Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1096-9896 |
EndPage | 61 |
ExternalDocumentID | 3770947621 25925728 10_1002_path_4552 PATH4552 ark_67375_WNG_1Z8F7PWX_W |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1KJ 1L6 1OB 1OC 1ZS 29L 31~ 33P 3O- 3SF 3UE 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA GSXLS H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M68 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 V2E VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XPP XV2 YQI YQJ ZGI ZXP ZZTAW ~IA ~KM ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c4612-b75bf4a0ce176d4203261e6ddf884ff2c9c0065af19e054d9c0af5d274b0b9803 |
IEDL.DBID | DR2 |
ISSN | 0022-3417 1096-9896 |
IngestDate | Fri Jul 11 14:05:23 EDT 2025 Fri Jul 25 12:07:24 EDT 2025 Mon Jul 21 06:00:34 EDT 2025 Tue Jul 01 04:21:13 EDT 2025 Thu Apr 24 22:56:04 EDT 2025 Wed Jan 22 17:04:33 EST 2025 Wed Oct 30 09:52:32 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | migration ghrelin renal cell carcinoma Snail metastasis E-cadherin |
Language | English |
License | Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4612-b75bf4a0ce176d4203261e6ddf884ff2c9c0065af19e054d9c0af5d274b0b9803 |
Notes | ark:/67375/WNG-1Z8F7PWX-W istex:0271617852D2D5AB2E414650516D0AB2D1438A18 Appendix S1 Supplementary materials and methodsExpression profile of ghrelin in matched renal clear cell carcinomas and adjacent normal tissue. Ghrelin levels in 48 matched renal clear cell carcinomas and adjacent normal tissue were compared. Raw data were retrieved from microarray dataset KIRC gene expression (IlluminaHiSeq); T, tumour; N, normal. Relative difference in ghrelin expression was obtained by GhrelinT - GhrelinN; differences above ± 0.5 were considered as threshold and are shownRelative expression of ghrelin in RCC cell lines. Expression of the molecules indicated was evaluated by western blot in cell lines 769-P, 786-0, A-498, A-704 and ACHNRCC cell proliferation is not affected by ghrelin: 1 × 104 cells of (A-C) 786-0, ACHN and A-498, with 0, 90, 180 and 360 nm ghrelin, and (D, E) 769-P and 786-0 cells with ghrelin knockdown were seeded in cell culture plates. Cell numbers were counted at time points of 48 and 96 h. NS, non-silence control; sh4 and sh6, ghrelin knockdown clonesGhrelin promotes RCC cell migration in vitro. Cells were treated with 0, 90, 180 and 360 nm ghrelin for 48 h. Level of cell migration was evaluated by wound-healing assay, and representative images of cell migration are shownGhrelin treatment-mediated cell migration is reduced upon ghrelin knockdown. The indicated 786-0 cells were treated with 360 nm ghrelin. Cell migration was evaluated by Transwell assay (A, B) and wound-healing assay (C, D)Bioinformatics analysis of gene expression profile identifies an association between ghrelin, EMT and Snail signalling. Representative network showing the regulation of ghrelin in relation to the knowledge-based interaction molecules of Snail. The network was built based on the Snail interactome in the IPA database overlaid with the microarray data from ghrelin treatment of 786-0 cells. The intensity of the node colour indicates the degree of (red) up- and (green) down-regulation following ghrelin treatment in 786-0 cells; symbols are illustrated in the table (right)Ghrelin induces EMT. Cells were treated with 180 nm ghrelin for 48 h prior to immunofluorescence staining. The expression and distribution of N-cadherin, MMP9 and Twist are shown. Nuclear twist and nuclei (Hoechst-stained) are indicated by arrows ArticleID:PATH4552 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 25925728 |
PQID | 1702086006 |
PQPubID | 1006392 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1702651188 proquest_journals_1702086006 pubmed_primary_25925728 crossref_citationtrail_10_1002_path_4552 crossref_primary_10_1002_path_4552 wiley_primary_10_1002_path_4552_PATH4552 istex_primary_ark_67375_WNG_1Z8F7PWX_W |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2015 |
PublicationDateYYYYMMDD | 2015-09-01 |
PublicationDate_xml | – month: 09 year: 2015 text: September 2015 |
PublicationDecade | 2010 |
PublicationPlace | Chichester, UK |
PublicationPlace_xml | – name: Chichester, UK – name: England – name: Bognor Regis |
PublicationTitle | The Journal of pathology |
PublicationTitleAlternate | J. Pathol |
PublicationYear | 2015 |
Publisher | John Wiley & Sons, Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Ltd – name: Wiley Subscription Services, Inc |
References | Ueberberg B, Unger N, Saeger W, et al. Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009; 41: 814-821. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83. Hu CT, Wu JR, Chang TY, et al. The transcriptional factor Snail simultaneously triggers cell cycle arrest and migration of human hepatoma HepG2. J Biomed Sci 2008; 15: 343-355. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525. Wu Y, Zhou BP. TNFα/NF-κB/Snail pathway in cancer cell migration and invasion. Br J Cancer 2010; 102: 639-644. Cardiff RD. Epithelial to mesenchymal transition tumors: fallacious or Snail's pace? Clin Cancer Res 2005; 11: 8534-8537. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-166. Aybar MJ, Nieto MA, Mayor R. Snail precedes Slug in the genetic cascade required for the specification and migration of the Xenopus neural crest. Development 2003; 130: 483-494. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 2004; 16: 14-23. Lehembre F, Yilmaz M, Wicki A, et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J 2008; 27: 2603-2615. Park S, Jiang H, Zhang H, et al. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc Natl Acad Sci USA 2012; 109: 19003-19008. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-940. Mori K, Yoshimoto A, Takaya K, et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 2000; 486: 213-216. Toshinai K, Mondal MS, Nakazato M, et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001; 281: 1220-1225. Lo HW, Hsu SC, Xia W, et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007; 67: 9066-9076. Nagase Y, Takata K, Moriyama N, et al. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol 1995; 153: 798-801. Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metast 2009; 26: 273-287. Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2001; 2: 551-560. Tsolakis AV, Portela-Gomes GM, Stridsberg M, et al. Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab 2004; 89: 3739-3744. Dixit VD, Weeraratna AT, Yang H, et al. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J Biol Chem 2006; 281: 16681-16690. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001; 2: 760-768. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373: 1119-1132. Ho MY, Tang SJ, Chuang MJ, et al. TNFα induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Mol Cancer Res 2012; 10: 1109-1119. Wang L, Chen Q, Li G, et al. Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells. Peptides 2012; 33: 92-100. Kojima M, Kangawa K. Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract. Curr Opin Pharmacol 2002; 2: 665-668. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-89. Dornonville de la Cour C, Bjorkqvist M, Sandvik AK, et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 2001; 99: 141-150. Yang Z, Rayala S, Nguyen D, et al. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res 2005; 65: 3179-3184. Luo WR, Li SY, Cai LM, et al. High expression of nuclear Snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma. Ann Surg Oncol 2012; 19: 2971-2979. Lidgren A, Bergh A, Grankvist K, et al. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1α. BJU Int 2008; 101: 480-484. Grille SJ, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63: 2172-2178. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996; 335: 865-875. Usami Y, Satake S, Nakayama F, et al. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 2008; 215: 330-339. Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654. Kageyama H, Funahashi H, Hirayama M, et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 2005; 126: 67-71. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-132. Acevedo VD, Gangula RD, Freeman KW, et al. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 2007; 12: 559-571. Du C, Zhang C, Hassan S, et al. Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. Cancer Res 2010; 70: 7810-7819. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004; 5: 816-826. Baldanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-1037. Duxbury MS, Waseem T, Ito H, et al. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun 2003; 309: 464-468. Perl AK, Wilgenbus P, Dahl U, et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-193. Hemavathy K, Ashraf SI, Ip YT. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 2000; 257: 1-12. Barnett BP, Hwang Y, Taylor MS, et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010; 330: 1689-1692. De Craene B, van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 2005; 17: 535-547. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454. Campbell SC, Flanigan RC, Clark JI. Nephrectomy in metastatic renal cell carcinoma. Curr Treat Options Oncol 2003; 4: 363-372. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913. Walter T, Chardon L, Hervieu V, et al. Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases. Eur J Endocrinol 2009; 161: 639-645. Graham TR, Zhau HE, Odero-Marah VA, et al. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 2008; 68: 2479-2488. Olmeda D, Moreno-Bueno G, Flores JM, et al. SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Res 2007; 67: 11721-11731. Lin TC, Lee TC, Hsu SL, et al. The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast. PLoS One 2011; 6: e16654.*Cited in Supplementary materials and methods Chen JH, Huang SM, Chen CC, et al. Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma cells. J Cell Biochem 2011; 112: 2931-2941. Yamamoto T, Seino Y, Fukumoto H, et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990; 170: 223-230. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-1623. 2009; 41 2000; 257 2010; 102 2004; 4 2004; 6 2002; 159 2004; 5 2012; 19 2005; 65 2000; 2 2008; 101 2011; 112 2012; 10 1998; 392 2000; 407 2008; 27 1990; 170 2003; 4 2008; 68 2009; 161 2000; 486 2006; 281 1996; 335 2001; 99 2010; 70 2007; 67 2001; 166 2001; 281 2004; 89 2002; 2 2008; 15 2002; 3 2009; 373 1995; 153 2011; 6 2007; 12 2012; 33 2009; 26 2012; 109 2003; 130 2003; 309 2004; 50 2004; 16 2005; 126 2010; 330 2008; 215 2001; 2 2005; 17 2003; 63 2005; 11 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_17_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_28_1 e_1_2_7_50_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_56_1 e_1_2_7_37_1 e_1_2_7_39_1 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_29_1 e_1_2_7_51_1 e_1_2_7_30_1 Grille SJ (e_1_2_7_49_1) 2003; 63 e_1_2_7_53_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_38_1 |
References_xml | – reference: Dornonville de la Cour C, Bjorkqvist M, Sandvik AK, et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 2001; 99: 141-150. – reference: Wang L, Chen Q, Li G, et al. Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells. Peptides 2012; 33: 92-100. – reference: Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 2004; 16: 14-23. – reference: Chen JH, Huang SM, Chen CC, et al. Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma cells. J Cell Biochem 2011; 112: 2931-2941. – reference: Yamamoto T, Seino Y, Fukumoto H, et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990; 170: 223-230. – reference: Mori K, Yoshimoto A, Takaya K, et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 2000; 486: 213-216. – reference: Perl AK, Wilgenbus P, Dahl U, et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-193. – reference: Yang Z, Rayala S, Nguyen D, et al. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res 2005; 65: 3179-3184. – reference: Hemavathy K, Ashraf SI, Ip YT. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 2000; 257: 1-12. – reference: Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metast 2009; 26: 273-287. – reference: Luo WR, Li SY, Cai LM, et al. High expression of nuclear Snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma. Ann Surg Oncol 2012; 19: 2971-2979. – reference: Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-89. – reference: Aybar MJ, Nieto MA, Mayor R. Snail precedes Slug in the genetic cascade required for the specification and migration of the Xenopus neural crest. Development 2003; 130: 483-494. – reference: Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373: 1119-1132. – reference: Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83. – reference: Tsolakis AV, Portela-Gomes GM, Stridsberg M, et al. Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab 2004; 89: 3739-3744. – reference: Nagase Y, Takata K, Moriyama N, et al. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol 1995; 153: 798-801. – reference: Lehembre F, Yilmaz M, Wicki A, et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J 2008; 27: 2603-2615. – reference: Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001; 2: 760-768. – reference: Toshinai K, Mondal MS, Nakazato M, et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001; 281: 1220-1225. – reference: Acevedo VD, Gangula RD, Freeman KW, et al. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 2007; 12: 559-571. – reference: Cardiff RD. Epithelial to mesenchymal transition tumors: fallacious or Snail's pace? Clin Cancer Res 2005; 11: 8534-8537. – reference: Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004; 5: 816-826. – reference: Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2001; 2: 551-560. – reference: Kageyama H, Funahashi H, Hirayama M, et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 2005; 126: 67-71. – reference: Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-166. – reference: Baldanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-1037. – reference: Lo HW, Hsu SC, Xia W, et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007; 67: 9066-9076. – reference: De Craene B, van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 2005; 17: 535-547. – reference: Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-132. – reference: Wu Y, Zhou BP. TNFα/NF-κB/Snail pathway in cancer cell migration and invasion. Br J Cancer 2010; 102: 639-644. – reference: Usami Y, Satake S, Nakayama F, et al. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 2008; 215: 330-339. – reference: Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-940. – reference: Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996; 335: 865-875. – reference: Barnett BP, Hwang Y, Taylor MS, et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010; 330: 1689-1692. – reference: *Lin TC, Lee TC, Hsu SL, et al. The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast. PLoS One 2011; 6: e16654.*Cited in Supplementary materials and methods – reference: Campbell SC, Flanigan RC, Clark JI. Nephrectomy in metastatic renal cell carcinoma. Curr Treat Options Oncol 2003; 4: 363-372. – reference: Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454. – reference: Du C, Zhang C, Hassan S, et al. Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. Cancer Res 2010; 70: 7810-7819. – reference: Graham TR, Zhau HE, Odero-Marah VA, et al. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 2008; 68: 2479-2488. – reference: Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913. – reference: Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654. – reference: Grille SJ, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63: 2172-2178. – reference: Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525. – reference: Duxbury MS, Waseem T, Ito H, et al. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun 2003; 309: 464-468. – reference: Hu CT, Wu JR, Chang TY, et al. The transcriptional factor Snail simultaneously triggers cell cycle arrest and migration of human hepatoma HepG2. J Biomed Sci 2008; 15: 343-355. – reference: Ueberberg B, Unger N, Saeger W, et al. Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009; 41: 814-821. – reference: Park S, Jiang H, Zhang H, et al. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. Proc Natl Acad Sci USA 2012; 109: 19003-19008. – reference: Ho MY, Tang SJ, Chuang MJ, et al. TNFα induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Mol Cancer Res 2012; 10: 1109-1119. – reference: Lidgren A, Bergh A, Grankvist K, et al. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1α. BJU Int 2008; 101: 480-484. – reference: Kojima M, Kangawa K. Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract. Curr Opin Pharmacol 2002; 2: 665-668. – reference: Dixit VD, Weeraratna AT, Yang H, et al. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J Biol Chem 2006; 281: 16681-16690. – reference: Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-1623. – reference: Walter T, Chardon L, Hervieu V, et al. Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases. Eur J Endocrinol 2009; 161: 639-645. – reference: Olmeda D, Moreno-Bueno G, Flores JM, et al. SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Res 2007; 67: 11721-11731. – volume: 11 start-page: 8534 year: 2005 end-page: 8537 article-title: Epithelial to mesenchymal transition tumors: fallacious or Snail's pace? publication-title: Clin Cancer Res – volume: 99 start-page: 141 year: 2001 end-page: 150 article-title: A‐like cells in the rat stomach contain ghrelin and do not operate under gastrin control publication-title: Regul Pept – volume: 89 start-page: 3739 year: 2004 end-page: 3744 article-title: Malignant gastric ghrelinoma with hyperghrelinemia publication-title: J Clin Endocrinol Metab – volume: 309 start-page: 464 year: 2003 end-page: 468 article-title: Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness publication-title: Biochem Biophys Res Commun – volume: 63 start-page: 2172 year: 2003 end-page: 2178 article-title: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines publication-title: Cancer Res – volume: 68 start-page: 2479 year: 2008 end-page: 2488 article-title: Insulin‐like growth factor‐I‐dependent up‐regulation of ZEB1 drives epithelial‐to‐mesenchymal transition in human prostate cancer cells publication-title: Cancer Res – volume: 70 start-page: 7810 year: 2010 end-page: 7819 article-title: Protein kinase D1 suppresses epithelial‐to‐mesenchymal transition through phosphorylation of snail publication-title: Cancer Res – volume: 41 start-page: 814 year: 2009 end-page: 821 article-title: Expression of ghrelin and its receptor in human tissues publication-title: Horm Metab Res – volume: 50 start-page: 1511 year: 2004 end-page: 1525 article-title: Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin publication-title: Clin Chem – volume: 109 start-page: 19003 year: 2012 end-page: 19008 article-title: Modification of ghrelin receptor signaling by somatostatin receptor‐5 regulates insulin release publication-title: Proc Natl Acad Sci USA – volume: 170 start-page: 223 year: 1990 end-page: 230 article-title: Over‐expression of facilitative glucose transporter genes in human cancer publication-title: Biochem Biophys Res Commun – volume: 335 start-page: 865 year: 1996 end-page: 875 article-title: Renal‐cell carcinoma publication-title: N Engl J Med – volume: 67 start-page: 11721 year: 2007 end-page: 11731 article-title: SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA‐MB‐231 cells publication-title: Cancer Res – volume: 161 start-page: 639 year: 2009 end-page: 645 article-title: Major hyperghrelinemia in advanced well‐differentiated neuroendocrine carcinomas: report of three cases publication-title: Eur J Endocrinol – volume: 130 start-page: 483 year: 2003 end-page: 494 article-title: Snail precedes Slug in the genetic cascade required for the specification and migration of the neural crest publication-title: Development – volume: 6 start-page: 931 year: 2004 end-page: 940 article-title: Dual regulation of Snail by GSK‐3β‐mediated phosphorylation in control of epithelial–mesenchymal transition publication-title: Nat Cell Biol – volume: 126 start-page: 67 year: 2005 end-page: 71 article-title: Morphological analysis of ghrelin and its receptor distribution in the rat pancreas publication-title: Regul Pept – volume: 68 start-page: 3645 year: 2008 end-page: 3654 article-title: Loss of E‐cadherin promotes metastasis via multiple downstream transcriptional pathways publication-title: Cancer Res – volume: 19 start-page: 2971 year: 2012 end-page: 2979 article-title: High expression of nuclear Snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma publication-title: Ann Surg Oncol – volume: 166 start-page: 1611 year: 2001 end-page: 1623 article-title: The changing natural history of renal cell carcinoma publication-title: J Urol – volume: 17 start-page: 535 year: 2005 end-page: 547 article-title: Unraveling signalling cascades for the Snail family of transcription factors publication-title: Cell Signal – volume: 67 start-page: 9066 year: 2007 end-page: 9076 article-title: Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial–mesenchymal transition in cancer cells via up‐regulation of TWIST gene expression publication-title: Cancer Res – volume: 6 start-page: e16654 year: 2011 article-title: The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast publication-title: PLoS One – volume: 26 start-page: 273 year: 2009 end-page: 287 article-title: The actin cytoskeleton in cancer cell motility publication-title: Clin Exp Metast – volume: 330 start-page: 1689 year: 2010 end-page: 1692 article-title: Glucose and weight control in mice with a designed ghrelin ‐acyltransferase inhibitor publication-title: Science – volume: 2 start-page: 76 year: 2000 end-page: 83 article-title: The transcription factor snail controls epithelial–mesenchymal transitions by repressing E‐cadherin expression publication-title: Nat Cell Biol – volume: 12 start-page: 559 year: 2007 end-page: 571 article-title: Inducible FGFR‐1 activation leads to irreversible prostate adenocarcinoma and an epithelial‐to‐mesenchymal transition publication-title: Cancer Cell – volume: 373 start-page: 1119 year: 2009 end-page: 1132 article-title: Renal cell carcinoma publication-title: Lancet – volume: 112 start-page: 2931 year: 2011 end-page: 2941 article-title: Ghrelin induces cell migration through GHS‐R, CaMKII, AMPK, and NF‐κB signaling pathway in glioma cells publication-title: J Cell Biochem – volume: 407 start-page: 908 year: 2000 end-page: 913 article-title: Ghrelin induces adiposity in rodents publication-title: Nature – volume: 3 start-page: 155 year: 2002 end-page: 166 article-title: The snail superfamily of zinc‐finger transcription factors publication-title: Nat Rev Mol Cell Biol – volume: 153 start-page: 798 year: 1995 end-page: 801 article-title: Immunohistochemical localization of glucose transporters in human renal cell carcinoma publication-title: J Urol – volume: 2 start-page: 84 year: 2000 end-page: 89 article-title: The transcription factor snail is a repressor of E‐cadherin gene expression in epithelial tumour cells publication-title: Nat Cell Biol – volume: 10 start-page: 1109 year: 2012 end-page: 1119 article-title: TNFα induces epithelial–mesenchymal transition of renal cell carcinoma cells via a GSK3β‐dependent mechanism publication-title: Mol Cancer Res – volume: 2 start-page: 551 year: 2001 end-page: 560 article-title: Ghrelin: an orexigenic and somatotrophic signal from the stomach publication-title: Nat Rev Neurosci – volume: 5 start-page: 816 year: 2004 end-page: 826 article-title: Integrin signalling during tumour progression publication-title: Nat Rev Mol Cell Biol – volume: 392 start-page: 190 year: 1998 end-page: 193 article-title: A causal role for E‐cadherin in the transition from adenoma to carcinoma publication-title: Nature – volume: 4 start-page: 118 year: 2004 end-page: 132 article-title: Cell adhesion and signalling by cadherins and Ig‐CAMs in cancer publication-title: Nat Rev Cancer – volume: 27 start-page: 2603 year: 2008 end-page: 2615 article-title: NCAM‐induced focal adhesion assembly: a functional switch upon loss of E‐cadherin publication-title: EMBO J – volume: 2 start-page: 665 year: 2002 end-page: 668 article-title: Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract publication-title: Curr Opin Pharmacol – volume: 15 start-page: 343 year: 2008 end-page: 355 article-title: The transcriptional factor Snail simultaneously triggers cell cycle arrest and migration of human hepatoma HepG2 publication-title: J Biomed Sci – volume: 16 start-page: 14 year: 2004 end-page: 23 article-title: Prespecification and plasticity: shifting mechanisms of cell migration publication-title: Curr Opin Cell Biol – volume: 486 start-page: 213 year: 2000 end-page: 216 article-title: Kidney produces a novel acylated peptide, ghrelin publication-title: FEBS Lett – volume: 101 start-page: 480 year: 2008 end-page: 484 article-title: Glucose transporter‐1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor‐1α publication-title: BJU Int – volume: 65 start-page: 3179 year: 2005 end-page: 3184 article-title: Pak1 phosphorylation of snail, a master regulator of epithelial‐to‐mesenchyme transition, modulates snail's subcellular localization and functions publication-title: Cancer Res – volume: 215 start-page: 330 year: 2008 end-page: 339 article-title: Snail‐associated epithelial–mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression publication-title: J Pathol – volume: 4 start-page: 363 year: 2003 end-page: 372 article-title: Nephrectomy in metastatic renal cell carcinoma publication-title: Curr Treat Options Oncol – volume: 2 start-page: 442 year: 2002 end-page: 454 article-title: Epithelial–mesenchymal transitions in tumour progression publication-title: Nat Rev Cancer – volume: 33 start-page: 92 year: 2012 end-page: 100 article-title: Ghrelin stimulates angiogenesis via GHSR1a‐dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells publication-title: Peptides – volume: 102 start-page: 639 year: 2010 end-page: 644 article-title: TNFα/NF‐κB/Snail pathway in cancer cell migration and invasion publication-title: Br J Cancer – volume: 281 start-page: 16681 year: 2006 end-page: 16690 article-title: Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility publication-title: J Biol Chem – volume: 2 start-page: 760 year: 2001 end-page: 768 article-title: PKB/AKT: functional insights from genetic models publication-title: Nat Rev Mol Cell Biol – volume: 281 start-page: 1220 year: 2001 end-page: 1225 article-title: Upregulation of Ghrelin expression in the stomach upon fasting, insulin‐induced hypoglycemia, and leptin administration publication-title: Biochem Biophys Res Commun – volume: 257 start-page: 1 year: 2000 end-page: 12 article-title: Snail/slug family of repressors: slowly going into the fast lane of development and cancer publication-title: Gene – volume: 159 start-page: 1029 year: 2002 end-page: 1037 article-title: Ghrelin and des‐acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3‐kinase/AKT publication-title: J Cell Biol – ident: e_1_2_7_54_1 doi: 10.1016/j.peptides.2011.11.001 – ident: e_1_2_7_14_1 doi: 10.1074/jbc.M600223200 – ident: e_1_2_7_11_1 doi: 10.1055/s-0029-1233462 – ident: e_1_2_7_10_1 doi: 10.1016/j.regpep.2004.08.031 – ident: e_1_2_7_44_1 doi: 10.1242/dev.00238 – ident: e_1_2_7_47_1 doi: 10.1158/0008-5472.CAN-07-2318 – volume: 63 start-page: 2172 year: 2003 ident: e_1_2_7_49_1 article-title: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines publication-title: Cancer Res – ident: e_1_2_7_39_1 doi: 10.1016/j.ccr.2007.11.004 – ident: e_1_2_7_43_1 doi: 10.1158/1078-0432.CCR-05-2250 – ident: e_1_2_7_31_1 doi: 10.1016/j.ceb.2003.11.001 – ident: e_1_2_7_12_1 doi: 10.1210/jc.2003-032118 – ident: e_1_2_7_2_1 doi: 10.1016/S0022-5347(05)65640-6 – ident: e_1_2_7_45_1 doi: 10.1007/s11373-007-9230-y – ident: e_1_2_7_15_1 doi: 10.1002/jcb.23209 – ident: e_1_2_7_30_1 doi: 10.1038/nrm1490 – ident: e_1_2_7_52_1 doi: 10.1158/0008-5472.CAN-09-4481 – ident: e_1_2_7_8_1 doi: 10.1016/S0014-5793(00)02308-5 – ident: e_1_2_7_36_1 doi: 10.1158/0008-5472.CAN-07-2938 – ident: e_1_2_7_33_1 doi: 10.1038/nrc1276 – ident: e_1_2_7_18_1 doi: 10.1038/nrm757 – ident: e_1_2_7_21_1 doi: 10.1016/0006-291X(90)91263-R – ident: e_1_2_7_37_1 doi: 10.1158/0008-5472.CAN-07-0575 – ident: e_1_2_7_53_1 doi: 10.1158/0008-5472.CAN-04-3480 – ident: e_1_2_7_4_1 doi: 10.1056/NEJM199609193351207 – ident: e_1_2_7_7_1 doi: 10.1016/S1471-4892(02)00220-5 – ident: e_1_2_7_28_1 doi: 10.1073/pnas.1209590109 – ident: e_1_2_7_22_1 doi: 10.1016/S0022-5347(01)67725-5 – ident: e_1_2_7_3_1 doi: 10.1007/s11864-003-0037-4 – ident: e_1_2_7_17_1 doi: 10.1016/j.cellsig.2004.10.011 – ident: e_1_2_7_16_1 doi: 10.1038/nrc822 – ident: e_1_2_7_46_1 doi: 10.1002/path.2365 – ident: e_1_2_7_34_1 doi: 10.1038/32433 – ident: e_1_2_7_42_1 doi: 10.1038/35000025 – ident: e_1_2_7_19_1 doi: 10.1038/ncb1173 – ident: e_1_2_7_13_1 doi: 10.1016/j.bbrc.2003.08.024 – ident: e_1_2_7_25_1 doi: 10.1038/35038090 – ident: e_1_2_7_40_1 doi: 10.1038/sj.bjc.6605530 – ident: e_1_2_7_23_1 doi: 10.1111/j.1464-410X.2007.07238.x – ident: e_1_2_7_5_1 doi: 10.1016/S0140-6736(09)60229-4 – ident: e_1_2_7_56_1 doi: 10.1371/journal.pone.0016654 – ident: e_1_2_7_9_1 doi: 10.1373/clinchem.2004.032482 – ident: e_1_2_7_32_1 doi: 10.1007/s10585-008-9174-2 – ident: e_1_2_7_29_1 doi: 10.1530/EJE-09-0073 – ident: e_1_2_7_27_1 doi: 10.1006/bbrc.2001.4518 – ident: e_1_2_7_6_1 doi: 10.1038/35086018 – ident: e_1_2_7_51_1 doi: 10.1083/jcb.200207165 – ident: e_1_2_7_26_1 doi: 10.1016/S0167-0115(01)00243-9 – ident: e_1_2_7_24_1 doi: 10.1126/science.1196154 – ident: e_1_2_7_35_1 doi: 10.1038/emboj.2008.178 – ident: e_1_2_7_55_1 doi: 10.1038/35096067 – ident: e_1_2_7_48_1 doi: 10.1245/s10434-012-2347-x – ident: e_1_2_7_50_1 doi: 10.1158/1541-7786.MCR-12-0160 – ident: e_1_2_7_38_1 doi: 10.1158/0008-5472.CAN-07-2559 – ident: e_1_2_7_41_1 doi: 10.1038/35000034 – ident: e_1_2_7_20_1 doi: 10.1016/S0378-1119(00)00371-1 |
SSID | ssj0009955 |
Score | 2.354995 |
Snippet | Ghrelin is an appetite‐regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS‐R).... Ghrelin is an appetite‐regulating molecule that promotes growth hormone ( GH ) release and food intake through growth hormone secretagogue receptor ( GHS ‐R).... Ghrelin is an appetite-regulating molecule that promotes growth hormone (GH) release and food intake through growth hormone secretagogue receptor (GHS-R).... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 50 |
SubjectTerms | Animals Binding Sites Cadherins - genetics Cadherins - metabolism Carcinoma, Renal Cell - genetics Carcinoma, Renal Cell - metabolism Carcinoma, Renal Cell - mortality Carcinoma, Renal Cell - secondary Cell Line, Tumor Cell Movement - drug effects E-cadherin Gene Expression Profiling - methods Gene Expression Regulation, Neoplastic ghrelin Ghrelin - genetics Ghrelin - metabolism Humans Kidney Neoplasms - genetics Kidney Neoplasms - metabolism Kidney Neoplasms - mortality Kidney Neoplasms - pathology Male metastasis Mice, Inbred NOD Mice, SCID migration Neoplasm Invasiveness Oligonucleotide Array Sequence Analysis Phosphatidylinositol 3-Kinase - antagonists & inhibitors Phosphatidylinositol 3-Kinase - metabolism Phosphorylation Promoter Regions, Genetic - drug effects Protein Kinase Inhibitors - pharmacology Proto-Oncogene Proteins c-akt - antagonists & inhibitors Proto-Oncogene Proteins c-akt - genetics Proto-Oncogene Proteins c-akt - metabolism Receptors, Ghrelin - genetics Receptors, Ghrelin - metabolism renal cell carcinoma RNA Interference Signal Transduction Snail Snail Family Transcription Factors Time Factors Transcription Factors - genetics Transcription Factors - metabolism Transfection |
Title | Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis |
URI | https://api.istex.fr/ark:/67375/WNG-1Z8F7PWX-W/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.4552 https://www.ncbi.nlm.nih.gov/pubmed/25925728 https://www.proquest.com/docview/1702086006 https://www.proquest.com/docview/1702651188 |
Volume | 237 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3_a9QwFH-MCeIvftfVTYkisl96a7ukTfGnId4OYWPoxh0ihHyF47b2uN4N8a83r2k7JhPEX0pLXtI0eS_5JH35PID3ylpb-okj9pMTXrSMVZYVsdXGZH714zKHB4VPTvPJBf0yY7Mt-NifhQn8EMOGG1pGO16jgUvVHNyQhmLE3hFlDMdf9NVCQPT1hjqqLBkbmMJpWvSsQkl2MOS8NRfdw2b9eRfQvI1b24ln_Ah-9FUO_iaL0WatRvrXH2yO__lNj-FhB0jJUdCgJ7Blq6dw_6T75f4MFse-t33JZNk67tmGrCxmwB1_ojESUVVfSXJl19IDzWbekOu5JN8qOb8keGgibPkSWRni02SnDdYQ3AEmy7peYcno7jdvnsPF-PP5p0ncRWiINc0xek_BlKMy0TYtckMxGnue2twYxzl1LtOlRowjXVpajw2Nf5SOGb8SVokqeXL4ArarurI7QGySoNLow4Lm1BmpOJdKe7zEuOFUywj2-74SuqMvxygalyIQL2cCG09g40XwbhBdBs6Ou4Q-tB0-SMjVAp3cCiamp8ci_c7Hxdl0JqYR7PUaITr7bkRaYHBTDxbzCN4Oyd4ysfFlZetNkMlxAccjeBk0aXiZX3T6sTLzKfutPvy9nuLs6HyCN6_-XXQXHnhcx4Ir3B5sr1cb-9pjp7V60xrJb_yqFt0 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED9KC9te1n22XttNG2P0xantSv6AvZSyNNuaULaUhMEQsiRDSGuHOBljf_3u_FU6Ohh7CQk624p0J_3ufPodwNvUWpvgxuHi5kQfWrlpEESu1cYE6P1kQUYHhYejcHDJP03FdAPet2dhan6ILuBGllGt12TgFJA-umENpZK9PS4ELsBbVNG7cqi-3JBHJYkQHVc496OWV8gLjrpLb-1GWzSwP--CmreRa7X19Lfhe9vpOuNk3luv0p7-9Qef4__-q0fwsMGk7KRWosewYfMncG_YvHV_CvMznHC8NVtUuXu2ZEtLF1DQn2kqRpQX14pd25VCrFnOSvZjptjXXM2uGJ2bqKO-TOWGYZtqFMIaRkFgtiiKJd2ZMv5m5TO47H8Ynw7cpkiDq3lIBXwikWZcedr6UWg4FWQPfRsak8Uxz7JAJ5pgjsr8xCI8NPhTZcKgM5x6aRJ7x89hMy9yuwvMeh7pjT6OeMgzo9I4VqlGyCRiE3OtHDhsJ0vqhsGcCmlcyZp7OZA0eJIGz4E3neiipu24S-hdNeOdhFrOKc8tEnIyOpP-t7gfXUymcuLAfqsSsjHxUvoR1TdFvBg68LprRuOkwVe5Lda1TEg-XOzATq1K3cPQ78TlMsCWw0oh_t5PeXEyHtCXF_8u-gruD8bDc3n-cfR5Dx4gzBN1Ztw-bK6Wa3uAUGqVvqws5jdOBRr4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFD6UFspetnZXr12njTH64tR2JVtmT6Vtml0awtaSUAZC1gVCWjvEyRj79dPxrXR0MPZibHQky9I50if56DsA7zJjTOomDt9NTnhR0s-iKPGN0jpyqx8bWTwofD6MB5f004RN1uBDexam5ofoNtzQMqrxGg18ru3BLWkoRuztUcbc-LtB44CjSp98veWOSlPGOqpwGiYtrVAQHXRZ70xGG9iuP-9DmneBazXz9B_B97bOtcPJrLdaZj316w86x__8qC142CBSclSr0DasmfwxbJ43_9yfwOzMdbcrmcwrzz1TkoXBDLjlTxSGIsqLG0luzFI6pFlOS_JjKsm3XE6vCZ6aqPd8icw1cWmyUQejCW4Bk3lRLLBk9Peblk_hsn96cTzwmxANvqIxhu9JWGapDJQJk1hTDMcehybW2nJOrY1UqhDkSBumxoFD7R6lZdothbMgS3lw-AzW8yI3L4CYIECtUYcJjanVMuNcZsoBJsY1p0p6sN_2lVANfzmG0bgWNfNyJLDxBDaeB2870XlN2nGf0PuqwzsJuZihl1vCxHh4JsIr3k9G44kYe7DbaoRoDLwUYYLRTR1ajD140yU708TGl7kpVrVMjCs47sHzWpO6l7lVpxssI5eyX-nD3-spRkcXA7x5-e-ir2FzdNIXXz4OP-_AA4fxWO0Wtwvry8XKvHI4apntVfbyGw62GbA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ghrelin+promotes+renal+cell+carcinoma+metastasis+via+Snail+activation+and+is+associated+with+poor+prognosis&rft.jtitle=The+Journal+of+pathology&rft.au=Lin%2C+Tsung-Chieh&rft.au=Liu%2C+Yu-Peng&rft.au=Chan%2C+Yung-Chieh&rft.au=Su%2C+Chia-Yi&rft.date=2015-09-01&rft.pub=John+Wiley+%26+Sons%2C+Ltd&rft.issn=0022-3417&rft.eissn=1096-9896&rft.volume=237&rft.issue=1&rft.spage=50&rft.epage=61&rft_id=info:doi/10.1002%2Fpath.4552&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_1Z8F7PWX_W |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon |